Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Invesco S&P 500 Low Volatility ETF
SPLV
$7.22B
| $620K | ﹤0.01% |
8,300
-3,710
| -31% | -$268K |
|
3327
GoodRx Holdings
GDRX
$1.27B
| $618K | ﹤0.01% |
140,090
-25,838
| -16% | -$121K |
|
|
DHC
3328
Diversified Healthcare Trust
DHC
$2.03B
| $613K | ﹤0.01% |
255,550
-108,515
| -30% | -$268K |
|
3329
Daktronics
DAKT
$988M
| $613K | ﹤0.01% |
50,344
-19,249
| -28% | -$291K |
|
3330
Cytek Biosciences
CTKB
$636M
| $613K | ﹤0.01% |
152,863
-62,561
| -29% | -$324K |
|
3331
Urban One Class D
UONEK
$24.1M
| $613K | ﹤0.01% |
85,124
+9,401
| +12% | +$74.3K |
|
3332
Keros Therapeutics
KROS
$211M
| $610K | ﹤0.01% |
59,860
-47,682
| -44% | -$554K |
|
3333
York Water
YORW
$536M
| $609K | ﹤0.01% |
17,570
-7,154
| -29% | -$233K |
|
3334
Rocket Companies
RKT
$42.6B
| $609K | ﹤0.01% |
50,473
-702,872
| -93% | -$9.07M |
|
|
VPU
3335
Vanguard Utilities ETF
VPU
$8.52B
| $608K | ﹤0.01% |
3,560
+2,621
| +279% | +$443K |
|
3336
CALL
Lamb Weston
LW
$7.39B
| $608K | ﹤0.01% |
11,400
-47,200
| -81% | -$2.67M |
|
|
FFWM
3337
DELISTED
First Foundation Inc
FFWM
| $606K | ﹤0.01% |
116,838
-30,121
| -20% | -$162K |
|
|
GRFS
3338
Grifois
GRFS
$5.4B
| $606K | ﹤0.01% |
85,175
+1,757
| +2% | +$13.3K |
|
3339
CALL
Constellium
CSTM
$3.95B
| $605K | ﹤0.01% |
+60,000
| New | +$638K |
|
3340
PUT
Lucid Motors
LCID
$2.54B
| $605K | ﹤0.01% |
25,000
-201,800
| -89% | -$5.4M |
|
|
CHCT
3341
Community Healthcare Trust
CHCT
$433M
| $605K | ﹤0.01% |
33,309
-13,671
| -29% | -$261K |
|
3342
Sigma Lithium
SGML
$1.27B
| $603K | ﹤0.01% |
57,960
-5,541
| -9% | -$63.6K |
|
3343
Scholastic
SCHL
$784M
| $603K | ﹤0.01% |
31,926
-9,254
| -22% | -$185K |
|
3344
CALL
Credo Technology Group
CRDO
$49.6B
| $602K | ﹤0.01% |
+15,000
| New | +$932K |
|
3345
Smith & Wesson
SWBI
$643M
| $602K | ﹤0.01% |
64,606
-20,554
| -24% | -$212K |
|
3346
Backblaze
BLZE
$1.26B
| $602K | ﹤0.01% |
124,653
+39,365
| +46% | +$242K |
|
3347
Rogers Communications
RCI
$19.7B
| $601K | ﹤0.01% |
22,495
-147,575
| -87% | -$4.17M |
|
3348
Mission Produce
AVO
$1.15B
| $601K | ﹤0.01% |
57,356
-17,429
| -23% | -$203K |
|
3349
PUT
SentinelOne
S
$8.17B
| $600K | ﹤0.01% |
+33,000
| New | +$716K |
|
3350
Ameresco
AMRC
$1.47B
| $600K | ﹤0.01% |
49,632
-15,309
| -24% | -$277K |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.